Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial
暂无分享,去创建一个
F. Feuerhake | N. Harbeck | O. Gluz | S. Kuemmel | R. Kates | U. Nitz | R. Wuerstlein | M. Warm | H. Forstbauer | C. Schumacher | M. Braun | M. Christgen | B. Aktas | J. Hackmann | M. Graeser | C. Uleer | H. Kreipe | C. Kolberg-Liedtke | M. Garke | E. Grischke